Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul;59(4):269-272.
doi: 10.4132/jptm.2025.06.19. Epub 2025 Jul 10.

What's new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney

Affiliations

What's new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney

Astrid Weins et al. J Pathol Transl Med. 2025 Jul.

Abstract

Diffuse podocytopathy, including minimal change disease and primary focal segmental glomerulosclerosis, is a common cause of nephrotic syndrome in adults and children. It is increasingly recognized to be autoimmune-mediated associated with anti-nephrin and other emerging anti-slit diaphragm antibodies, and can recur in the kidney allograft. Immunofluorescence is routinely used in evaluation of kidney biopsies, and updates include those on fibrillar diseases, monoclonal staining, lupus-like staining, and use of antibody KM55 in IgA-dominant glomerulonephritis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Immunofluorescence staining in diffuse podocytopathy (DP) (Scale bars 20um) (contributed by Dr. Weins). (A) Fine punctate podocyte IgG in autoimmune DP. (B) Overlap of IgG and nephrin in anti-nephrin DP. (C) DP lacking overlap of background IgG with nephrin.
Fig. 2.
Fig. 2.
Immunofluorescence features of fibrillary glomerulonephritis (contributed by Dr. Alexander). Monotypic staining on fibrillary glomerulonephritis on routine immunofluorescence microscopy should prompt paraffin IF, IgG subclass, and DNAJB9 staining.
Fig. 3.
Fig. 3.
KM55 staining in primary and secondary forms of IgA nephropathy. Renal biopsy from a 28-year-old male who had previously undergone right hemicolectomy for Crohn’s disease, presenting with elevated creatinine, subnephrotic proteinuria, hematuria, and negative serologies. (A) Mesangioproliferative pattern of glomerular injury with segmental sclerosis (PAS, 200×). (B) 3+ mesangial granular staining for IgA, and (C) 3+ mesangial granular staining for KM55 (contributed by Drs. Singh and Raj).

Similar articles

  • Autoantibodies Targeting Nephrin in Podocytopathies.
    Hengel FE, Dehde S, Lassé M, Zahner G, Seifert L, Schnarre A, Kretz O, Demir F, Pinnschmidt HO, Grahammer F, Lucas R, Mehner LM, Zimmermann T, Billing AM, Oh J, Mitrotti A, Pontrelli P, Debiec H, Dossier C, Colucci M, Emma F, Smoyer WE, Weins A, Schaefer F, Alachkar N, Diemert A, Hogan J, Hoxha E, Wiech T, Rinschen MM, Ronco P, Vivarelli M, Gesualdo L, Tomas NM, Huber TB; International Society of Glomerular Disease. Hengel FE, et al. N Engl J Med. 2024 Aug 1;391(5):422-433. doi: 10.1056/NEJMoa2314471. Epub 2024 May 25. N Engl J Med. 2024. PMID: 38804512
  • Management of urinary stones by experts in stone disease (ESD 2025).
    Papatsoris A, Geavlete B, Radavoi GD, Alameedee M, Almusafer M, Ather MH, Budia A, Cumpanas AA, Kiremi MC, Dellis A, Elhowairis M, Galán-Llopis JA, Geavlete P, Guimerà Garcia J, Isern B, Jinga V, Lopez JM, Mainez JA, Mitsogiannis I, Mora Christian J, Moussa M, Multescu R, Oguz Acar Y, Petkova K, Piñero A, Popov E, Ramos Cebrian M, Rascu S, Siener R, Sountoulides P, Stamatelou K, Syed J, Trinchieri A. Papatsoris A, et al. Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
  • Sexual Harassment and Prevention Training.
    Cedeno R, Bohlen J. Cedeno R, et al. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
  • Epidemiology of glomerular diseases in a Colombian population.
    Rodelo-Ceballos J, Chávez-Gómez WF, Taborda-Murillo A, Arias LF. Rodelo-Ceballos J, et al. Rev Esp Patol. 2025 Jul-Sep;58(3):100813. doi: 10.1016/j.patol.2025.100813. Epub 2025 Feb 25. Rev Esp Patol. 2025. PMID: 40009975
  • Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.
    Mukherjee A, Roy D, Chakravarty A. Mukherjee A, et al. Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8. Curr Neurol Neurosci Rep. 2025. PMID: 40591029 Review.

References

    1. Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33:238–52. - PMC - PubMed
    1. Hengel FE, Dehde S, Lasse M, Zahner G, Seifert L, Schnarre A, et al. Autoantibodies targeting nephrin in podocytopathies. N Engl J Med. 2024;391:422–33. - PubMed
    1. Hengel FE, Dehde S, Kretz O, Engesser J, Zimmermann T, Huber TB, et al. Passive transfer of patient-derived anti-nephrin autoantibodies causes a podocytopathy with minimal change lesions. J Clin Invest. 2025;135:e186769. - PMC - PubMed
    1. Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J, et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 2024;105:608–17. - PubMed
    1. Batal I, Watts AJB, Gibier JB, Hamroun A, Top I, Provot F, et al. Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft. Kidney Int. 2024;106:749–52. - PMC - PubMed

LinkOut - more resources